FILE - This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company.
A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness†is related to the shot, the company announced Monday, Oct.
(Cheryl Gerber/Courtesy of Johnson & Johnson via AP, File).
FILE - This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company.
A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness†is related to the shot, the company announced Monday, Oct.
(Cheryl Gerber/Courtesy of Johnson & Johnson via AP, File).